Evidence map›Paper›PMID 41586522›Full record

Trial reportmSphere2026

The vaginal microbiome of pregnant people living with HIV on antiretroviral therapy in the Democratic Republic of Congo: a pilot study and global meta-analysis.

Kimberley S Ndlovu, Ricardo R Pavan, Jacqueline Corry, Ann C Gregory, Samia Mahamed, Natalia Zotova, Martine Tabala, Pelagie Babakazo, Nicholas T Funderburg, Marcel Yotebieng and 3 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in mSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03048669 (Continuous Quality Improvement Interventions to Improve Long Term Outcomes of Antiretroviral Therapy in Women Initiated on Therapy During Pregnancy or Breastfeeding in the Democratic Republic of Congo), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03048669 nacompletednot on this map

Continuous Quality Improvement Interventions to Improve Long Term Outcomes of Antiretroviral Therapy in Women Initiated on Therapy During Pregnancy or Breastfeeding in the Democratic Republic of Congo

TypeinterventionalSponsorAlbert Einstein College of MedicineRan2016 to 2022Enrolled5,053ConditionsHIV/AIDS, Antiretroviral Therapy, Pregnancy Outcomes, HIV-exposed InfantsArmsContinuous quality improvement
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Kimberley S Ndlovu *Department of Microbiology, The Ohio State University, Columbus, Ohio, USA.ORCID 0000-0001-6188-6261
Ricardo R Pavan *Department of Microbiology, The Ohio State University, Columbus, Ohio, USA.ORCID 0000-0002-7878-2861
Jacqueline CorryDepartment of Microbiology, The Ohio State University, Columbus, Ohio, USA.
Ann C GregoryDepartment of Biological Science, University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0003-4892-5611
Samia MahamedDepartment of Microbiology, The Ohio State University, Columbus, Ohio, USA.
Natalia ZotovaAlbert Einstein College of Medicine, Bronx, New York, USA.
Martine TabalaKinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.
Pelagie BabakazoKinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.
Nicholas T FunderburgDivision of Medical Laboratory Science, School of Health and Rehabilitation Sciences, The Ohio State University, Columbus, Ohio, USA.
Marcel YotebiengAlbert Einstein College of Medicine, Bronx, New York, USA.
Nichole R KlattDepartment of Surgery, Division of Surgical Outcomes and Precision Medicine Research, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0003-2968-5480
Jesse J KwiekDepartment of Microbiology, The Ohio State University, Columbus, Ohio, USA.ORCID 0000-0003-4277-8315
Matthew B SullivanDepartment of Microbiology, The Ohio State University, Columbus, Ohio, USA.ORCID 0000-0001-8398-8234

Funding

Eunice Kennedy Shriver National Institute of Child Health and Human Development R01HD087993Eunice Kennedy Shriver National Institute of Child Health and Human Development R01HD105526
6 · The paper itself

Abstract

Recent studies reveal that a suboptimal vaginal microbiome (VMB), including the enrichment of anaerobic bacteria associated with multiple female genital disorders, is linked to adverse pregnancy and birth outcomes in pregnant people. Problematically, however, the majority of the available data, to date, is biased toward highly developed, Global North countries, leaving underrepresented populations like the Democratic Republic of the Congo (DRC) poorly characterized. Here, we investigate the VMB from a cohort of 82 pregnant people living with human immunodeficiency virus (PLWH) on antiretroviral therapy (ART) from the DRC. Specifically, we explore the associations between the VMB via 16S rRNA gene sequencing and maternal peripheral immune factors. Additionally, we compare the VMB of pregnant PLWH-ART from DRC with publicly available VMB data (5 studies, 1861 samples) in a meta-analysis to elucidate the impact of HIV on the VMB. Combined, these analyses revealed the differences in community structure and predicted function of the microbiota between pregnant PLWH-ART and pregnant people without HIV (PWoH). Taxonomically, the VMB of DRC PLWH-ART were enriched for IMPORTANCE: Human immunodeficiency virus (HIV) remains prevalent in sub-Saharan Africa, where it has been linked to adverse birth outcomes. Suboptimal vaginal microbiomes (VMBs) have shown similar links. This pilot study fills critical gaps in understanding how HIV interacts with the pregnant VMB in populations underrepresented in microbiome research, like the Democratic Republic of the Congo (DRC). We identified maternal systemic immune factors associated with suboptimal VMBs that have been linked to poor birth outcomes. In a global meta-analysis, we found significant taxonomic and functional differences in the VMBs between pregnant people living with and without HIV, revealing potential biomarkers that increase the risk of adverse birth outcomes. These findings provide crucial insights into VMB features that may influence pregnancy health in PLWH-ART, guiding future research and tailored interventions to support safer pregnancies in the DRC and similar populations.This study is registered with NCT03048669.

Indexed as

Anti-Retroviral AgentsHIV InfectionsMicrobiotaPregnancy Complications, InfectiousVaginaAdultBacteriaDemocratic Republic of the CongoFemaleHumansPilot ProjectsPregnancyRNA, Ribosomal, 16SAnti-Retroviral AgentsRNA, Ribosomal, 16Santiretroviral therapyglobal healthhuman immunodeficiency virushuman microbiomemetaanalysisvaginal microbiome

Identifiers

PMID41586522
PMCPMC12931276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.